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The endothelial angiotensin I-converting enzyme (ACE) is organized in two large homologous domains, each bearing 
a putative active site. However, only one of these sites is probably involved in catalyzing the conversion of angiotensin 
I into angiotensin II. The testicular form of ACE is equally active, encoded by the same gene, but translated from a 
shorter mRNA. Molecular cloning of the human testicular ACE cDNA indicates that the mRNA codes for 732 residues 
(vs 1306 in endothelium). The testicular transcript corresponds to the 3’ half of the endothelial transcript and encodes 
one of the two homologous domains of endothelial ACE, preceded by a short specific sequence. This 5’ specific sequence 
contains 228 nucleotides and encodes 67 amino acids, including the putative signal peptide followed by a serine/threonine- 
enriched region, presumably glycosylated. The testicular transcript corresponds to the ancestral, non-duplicated form 
of the ACE gene. Since the carboxyl-terminal domain of the endothelial ACE is expressed in the testicular enzyme, it 
is likely that it bears the active site in both forms. 
Molecular cloning; Metalloproteinase; Membrane protein; Differential splicing; (Germ cell) 
1. INTRODUCTION 
Two immunologically and enzymatically related 
forms of angiotensin-I converting enzyme 
[peptidyl-dipeptide hydrolase, EC 3.4.15.1 (ACE)] 
are present in mammals. Whereas in vascular en- 
dothelial and absorptive epithelial cells ACE is in 
the large, single-chain, membrane-bound form 
with a molecular mass of around 170 kDa, in male 
germ cells it is synthesized as a shorter polypeptide 
and of approx. 100 kDa [l-4]. Molecular cloning 
of human endothelial ACE cDNA allowed us to 
establish that the testicular and endothelial en- 
zymes are encoded by two structurally related 
mRNAs of different length, 3.0 and 4.3 kb, 
respectively, both transcribed from a single gene 
[5]. We undertook the cloning of human testicular 
ACE cDNA to elucidate the structural relationship 
between both forms of ACE. Further interest in 
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this study arose from the observation in en- 
dothelial ACE of internal homology between two 
large peptide domains, each bearing a putative ac- 
tive site. Our results show that only one of the two 
domains is expressed in the testicular enzyme, 
although this enzyme displays enzymatic proper- 
ties apparently identical to those of endothelial 
ACE. 
2. MATERIALS AND METHODS 
2.1. Preparation and screening of cDNA libraries 
A human testis cDNA library, primed with oligo(dT) and 
constructed in bacteriophage Xgtl 1 (Clontech, Palo Alto, CA), 
was screened with the “P-labeled hHEC1922 cDNA clone 
previously isolated in this laboratory and corresponding to the 
nucleotide sequence of the human endothelial ACE mRNA 
from position 691 to 4024 [5]. hHEC1922 cDNA was labeled us- 
ing the random primer method [a]. Procedures for screening the 
A phage cDNA library, hybridization with the labeled probe and 
washing under stringent conditions were as described in [5] ae- 
cording to Benton and Davis [7]. Clones corresponding to the 
3’ part of the testicular cDNA were obtained (fig.1). A syn- 
thetic oligomer (TH16), corresponding to the nucleotide se- 
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- ACE mRNA, a specifically primed cDNA library was con- 
, A AhtlO strutted using 5 pg poly(A) RNA from human testis. Total 
8 , ihI RNA was extracted from a surgical specimen by the guanidine- 
c I Ah1341 cesium chloride method of Chirgwin et al. [8] and purified twice 
_ Ah1221 on d(T), cellulose (Pharmacia-LKB, Uppsala). Synthesis of the 
cDNA was primed with a 17-base oligomer (ATH17) com- 
Fig. 1. Schematic representation of four independent cDNA plementary to the nucleotide sequence from position 228 to 244 
clones of the testicular angiotensin I-converting enzyme. Clones of testicular ACE cDNA, together with d(T)rz-is. Subsequent 
AhtlO, hht16 and hht341 were obtained from the oligo(dT)- steps for library construction in XgtlO were performed accor- 
primed cDNA library, hht221 from that primed with ding to Koenig et al. [9]. Recombinant phages (1 x IO6 clones) 
oligonucleotide ATHl7. were screened with the TH16 oligomer under the same condi- 
tions as above. 
2.2. Nucleotide sequencing 
Phage inserts were subcloned into the EcoRl site of plasmid 
quence from position 59 to 80 of testicular cDNA (fig.2), was vector pBluescript (Stratagene, San Diego, CA). Double- 
synthesized and used as a probe to screen the cDNA library stranded DNA was sequenced on both strands using the 
again. The probe was labeled with T4 polynucleotide kinase and modified T7 polymerase (Sequenase, US Biochemicals, 
[y-“P]ATP. Filters were hybridized with the labeled oligomer Cleveland, OH). Sequencing reactions were primed either with 
at 60°C and finally washed at 65°C in 2 x SSC [5]. the universal primers or with 20/22-mer primers synthesized ac- 
In order to obtain clones containing the 5 ‘-end of testicular cording to confirmed cDNA sequences. 
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3. RESULTS 
By screening 2 x lo6 clones of the oligo-d(T)- 
primed testis library with endothelial clone 
hHEC1922, which gave strong hybridization with 
testicular poly(A) RNA by Northern blot analysis 
[5], 17 putative clones were obtained. Two of the 
clones, hhtl0 and hhtl6, bearing 2.2 and 2.3 kb in- 
serts respectively, were sequenced. They contain a 
sequence identical to the 3’ part of endothelial 
ACE cDNA, but extend more in the 3 ’ un- 
translated region. Clone hhtl0 contains the longest 
3 ’ untranslated region with a polyadenylation 
signal ATTAAA followed by a poly(A) tail and 
spans nucleotide positions 260-2477 of ACE 
testicular cDNA (fig.1). This unusual polyadenyla- 
tion sequence has been already found in other 
mammalian genes [lo]. The nucleotide sequence of 
this clone matches completely with the 3 ’ sequenc- 
ed part of the endothelial ACE mRNA [5]. Clone 
Xhtl6 corresponds to positions 50-2313 of 
testicular ACE mRNA. Upstream of nucleotide 
position 228, the sequence of the cDNA displays 
no similarity to that of endothelial ACE cDNA 
(figs 2,3). After a second screening of the cDNA 
library with oligomer TH16, corresponding to the 
5’ part of clone hhtl6 (see above), clone hht341 
was obtained. This clone, 2.2 kb in length, has a 
sequence identical to that of Aht16, including the 
5 ’ testicular specific region, and extends 19 
nucleotides upstream to the 5 ’ extremity of hhtl6. 
No putative initiation codon ATG was found in 
the 5 ’ sequence of these clones. 
The cDNA corresponding to the 5’-end of the 
mRNA was obtained from the testis cDNA library 
primed with oligomer ATH 17 (see section 2). Eight 
positive clones were obtained by screening this 
library with the oligomer TH16. One of the clones, 
Xht22,244 bp in length, was sequenced. It displays 
the 5 ’ part of the testicular ACE mRNA sequence 
with the putative initiator codon preceded by a 
28-base 5 ’ untranslated region (fig. 1). The consen- 
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Fig.3. Schematic representation f testicular and endothelial ACE. (Middle) Diagram showing cysteine positions, potential asparagine- 
linked glycosylation sites, and positions of putative residues of the active site of the two enzymes (HEMGH). Beyond the point of 
divergence, the testicular enzyme is shown on the upper line and the endothelial enzyme on the lower line. (Top, bottom) Hpdropathy 
plots of the predicted testicular (top) and endothelial [5] (bottom) amino acid sequences by the method of Kyte and Doolittle with 
a window size of 10 residues [18]. Negative values indicate increasing hydrophobicity. Amino acid numbering presented above and 
below the hydropathy plots. 
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sus sequence for initiation of translation is found 
from position 26 to 32 [ 111. 
The composite nucleotide sequence of the 
testicular ACE cDNA obtained from the four 
overlapping clones comprises 2477 nucleotides 
(fig.2). The open reading frame from the first 
ATG codon until the stop codon TGA encodes 732 
amino acids. The calculated molecular mass of the 
testicular ACE precursor is 83.2 kDa whereas its 
value was 149.5 kDa for the endothelial ACE [5]. 
In another clone, isolated from the oligo(dT)- 
primed cDNA library, a deletion of 97 bases is 
observed between nucleotide positions 130 and 228 
of testicular ACE cDNA. The sequence of the 5’ 
edge of the deletion is GT, preceded by AG, and 
has been recognized probably as an internal accep- 
tor site. The 3 ’ edge of the deletion corresponds to 
the junction between the specific testicular part of 
the mRNA and the common sequence with the en- 
dothelial mRNA. This aberrant splicing inside the 
3 ’ testicular exon generates another reading frame 
that terminates hortly thereafter by a stop codon. 
4. DISCUSSION 
Cloning of the cDNA for testicular ACE and 
alignment with cDNA for the endothelial enzyme 
indicate that the mRNAs of both enzymes hare in 
their 3 ’ region a large identical sequence that com- 
prises the last 1997 nucleotides of the coding se- 
quence. However, the 5 ’ part of the transcript 
differs between the two enzymes. In testicular 
cDNA, the 5’ part of the sequence down to the 
point of convergence with the sequence of the en- 
dothelial enzyme contains the initiator ATG codon 
followed by the sequence corresponding to the 
signal peptide (see below) and comprises 228 
nucleotides. This sequence is not found in the 
1943-nucleotide-long 5’ specific part of the en- 
dothelial enzyme cDNA [5]. As a unique gene en- 
codes both forms of ACE in man [5], the testicular 
and endothelial mRNAs may be generated by dif- 
ferential splicing of a common primary transcript. 
Alternatively, they could be transcribed from two 
different transcription start sites under the control 
of separate promoters [12]. This latter hypothesis 
is supported by our observation in genomic clones 
corresponding to the 5 ’ -end of testicular cDNA of 
a TATA-related sequence situated 19 bases 
102 
upstream of the 5 ’ extremity of testicular mRNA 
(Hubert, C. et al., in preparation). The presence of 
alternative promoters with different tissue 
specificity is also in agreement with probable dif- 
ferences in hormonal regulation. The testicular en- 
zyme is indeed expressed in the mature forms of 
germ cells [13-161 and is probably under the con- 
trol of androgens [17]. The demonstration of a 
functional testicular promoter requires further 
studies, such as transfection experiments. 
The protein sequence deduced from the 
testicular cDNA comprises 732 amino acids. The 
first 67 amino acids are translated by the specific 
testicular portion of the mRNA and therefore are 
not found in the endothelial enzyme. The last 665 
residues are identical to the carboxyl-terminal part 
of the endothelial ACE (fig.3). 
A computer search revealed no clear significant 
homology of the specific testicular part of the se- 
quence with any other protein found in the NBRF 
bank (release 19.0). No homology was found by 
alignment with the amino- or carboxyl-terminal 
peptide sequences reported for rabbit testicular 
ACE [ 191. The sequence begins with a peptide se- 
quence bearing the characteristics of a signal pep- 
tide [20]. The probable cleavage site of the signal 
peptide in the testicular enzyme, as predicted by 
the program of Von Heijne [21], is between amino 
acid positions 21 and 22. In endothelial ACE, the 
signal peptide is cleaved off during maturation and 
the enzyme becomes anchored to the plasma mem- 
brane by the 17-amino-acid transmembrane do- 
main situated near its carboxyl-terminal extremity 
[5]. The testicular enzyme, that is also, at least in 
part, in a membrane-bound form [15,22], 
possesses this transmembrane segment (fig.3). Like 
endothelial ACE, it may be anchored by this 
carboxyl-terminal region after cleavage of the 
signal peptide, although this should be confirmed 
by sequencing of the amino- and carboxyl-terminal 
extremities of the mature enzyme. 
The peptide sequence that follows the putative 
signal peptide is hydrophilic (fig.3) and has an 
unusually high content of threonine and serine: the 
sequence situated between Ser 28 and 65 contains 
47% threonine and serine. Similar serine- and 
threonine-enriched sequences are found in 
membrane-bound proteins, situated externally 
near the region of membrane insertion, e.g. in 
LDL receptor, aminopeptidase N, sucrase- 
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isomaltase complex, and interleukin II receptor, or 
close to the amino-terminal floating extremity in 
glycophorin A [23-281. They are potential sites of 
clustered 0-glycosylation. Evidence for clustered 
0-glycosylation has not been provided for the 
testicular ACE, but it is known that rabbit 
testicular ACE, in contrast to the pulmonary en- 
zyme, has a large content of N-acetylgalac- 
tosamine [ 11, a typical constituent of O-branched 
glycans [29]. This may reflect clustered O-glyco- 
sylation in the specific amino-terminal part of the 
testicular ACE sequence. 
The endothelial ACE molecule is organized in 
two large homologous domains separated by a 
short non-homologous region [5]. Identity with the 
testicular enzyme begins in the interdomain region 
and testicular ACE comprises only the carboxyl- 
terminal domain (fig.3). As discussed for the en- 
dothelial enzyme, this domain bears sequences 
identical to those located around critical residues 
of the other metallopeptidases, thermolysin, 
neutral endopeptidase and collagenase [5]. 
Therefore, His 414, 418 and Glu 442 are probably 
the amino acids coordinating the zinc atom in the 
testicular enzyme, with Glu 415 and His 457 being 
involved in catalysis. 
In the endothelial enzyme each of the two 
homologous domains bears a putative active site 
[5]. The testicular form of the enzyme, despite the 
presence of only one active site, apparently 
displays enzymatic properties identical to those of 
the endothelial enzyme, including the K, and tur- 
nover number for angiotensin I, as well as chloride 
dependency for hydrolysis [ 11. Its function in germ 
cells remains unknown and may not be related to 
angiotensin II formation. To date, there is no 
evidence of the testicular enzyme acting as a dimer. 
A lower molecular mass was indeed observed for 
the testicular vs pulmonary form of ACE by sub- 
mitting the native rabbit enzymes to density gra- 
dient centrifugation [ 11. The elucidation of the 
structure of the testicular enzyme suggests that 
despite the repetitive structure of endothelial ACE, 
only one of the two homologous domains ex- 
presses the dipeptidyl peptidase activity. This is 
also in agreement with the observation of a single 
zinc atom bound per molecule of endothelial ACE, 
and of a unique binding site for competitive in- 
hibitors (see [5]). Comparison with the testicular 
enzyme suggests that the carboxyl-terminal part of 
the molecule bears the active site in endothelial 
ACE. 
The results of this study, indicating that the 
testicular ACE transcript corresponds to only one 
of the two homologous regions of the endothelial 
transcript, are in agreement with the hypothesis 
that endothelial ACE resulted from gene duplica- 
tion. Testicular ACE mRNA indeed corresponds 
to transcription of the putative ancestral form of 
the gene, before the occurrence of duplication. 
This ancestral gene was apparently able to encode 
a fully active enzyme. The consequences for ACE 
activity, if any, of the appearance of the duplicated 
endothelial form remain to be established. 
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